ArticleClinical rheumatology2022
Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome.
Ran Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it